Anne E.G. Lenferink - Concepedia

Author

Anne E.G. Lenferink

Also Known As

A E G Lenferink, A E Lenferink, A. E.G. Lenferink, A. Lenferink, A.E. Lenferink, A.E.G. Lenferink, ANNE E. G. LENFERINK, Anne E. G. LENFERINK, Anne E. G. Lenferink, Anne E. Lenferink

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

National Research Council Canada Biotechnology Research Institute Radboud University Nijmegen National Academies of Sciences, Engineering, and Medicine Vanderbilt University

About

Anne E.G. Lenferink is an author at National Research Council Canada specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	1.3K
2	Engineering	5	5	85
3	Health Sciences	1	1	34
4	Natural Sciences	1	1	17
5	Allergy	1	1	18

Anne E.G. Lenferink

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers Anne E.G. Lenferink The EMBO Journal Receptor HeterodimersSignal TransductionHetero-dimeric Erbb TyrosineSignaling PathwayG Protein-coupled Receptor	1998	407
Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells. Hirokazu Kurokawa, Anne E.G. Lenferink, Jean F. Simpson, PubMed Tumor BiologyBreast OncologyEndocrine-related CancerTamoxifen ResistanceMitogen-activated Protein Kinases	2000	367
Identification of high-quality cancer prognostic markers and metastasis network modules Jie Li, Anne E.G. Lenferink, Yinghai Deng, Nature Communications	2010	262
ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways. Anne E.G. Lenferink, Dagmar Busse, W. Michael Flanagan, PubMed P27 LevelsErbb2 KinaseMolecular BiologyCancer BiologyCellular Physiology	2001	180
Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-α bigenic mice Anne E.G. Lenferink, Jean F. Simpson, Laura K. Shawver, Proceedings of the National Academy of Sciences	2000	128
ErbB2/Neu-Induced, Cyclin D1-Dependent Transformation Is Accelerated in <i>p27</i>-Haploinsufficient Mammary Epithelial Cells but Impaired in <i>p27</i>-Null Cells Rebecca S. Muraoka, Anne E.G. Lenferink, Brian K. Law, Molecular and Cellular Biology	2002	118
The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin Ronit Pinkas‐Kramarski, Anne E.G. Lenferink, Sarah Bacus, Oncogene Epidermal Growth FactorDevelopmental BiologySignal TransductionReceptor Tyrosine KinaseOncogenic Erbb-2/erbb-3 Heterodimer	1998	99
Transcriptome profiling of a TGF-β-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies Anne E.G. Lenferink, Christiane Cantin, André Nantel, Oncogene Signal TransductionSignaling PathwayCell InteractionImmunologyTranscriptome Profiling	2009	80
Cyclin-Dependent Kinase Inhibitor P27Kip1 Is Required for Mouse Mammary Gland Morphogenesis and Function Rebecca S. Muraoka, Anne E.G. Lenferink, Jean F. Simpson, The Journal of Cell Biology	2001	77
Identification of the high affinity binding site of transforming growth factor-alpha (TGF-alpha) for the chicken epidermal growth factor (EGF) receptor using EGF/TGF-alpha chimeras. R.H. Kramer, Anne E.G. Lenferink, I.L. van Bueren-Koornneef, Journal of Biological Chemistry	1994	41

Page 1